Creatine kinase and its muscle/brain isoenzyme as potential biomarkers for cardiovascular disease risk: A cross-sectional analysis of a population-based cohort
PLOS One · 2025
DOI: 10.1371/journal.pone.0338025 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, 2025. Verfasst von Mahla Izadpanah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Creatine Kinase, Creatine Kinase, MB Form, Brain. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study examines the correlation between creatine kinase (CK) and its muscle/brain isoenzyme (CK-MB) in relation to cardiovascular risk factors, highlighting sex disparities.
Methods
A three-year cross-sectional study was conducted among 246 adults recruited from the Mashhad University of Medical Sciences (MUMS) Persian Cohort. CK and CK-MB concentrations were measured using standardized laboratory assays. Correlations and multivariable linear models were used to assess associations with cardiovascular risk indicators.
Results
Men exhibited significantly higher log-transformed CK and CK-MB levels than women. Both enzymes showed weak-to-moderate correlations with selected cardiovascular parameters. Log CK was modestly associated with diastolic blood pressure (DBP), creatinine, and PWV (r < 0.29), whereas log CK-MB showed positive associations with calcium, potassium, DBP, and PWV. Many univariable associations attenuated after adjustment, with only serum calcium remaining independently related to log CK-MB (p = 0.03).
Conclusion
In this cross-sectional cohort, log CK and log CK-MB showed weak but statistically detectable associations with selected cardiovascular measures. These findings are hypothesis-generating and should be interpreted cautiously; they do not support clinical recommendations without prospective validation in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Social Departments of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
- Metabolic Syndrome Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Faculty of Medicine, Shahid Sadoghi University of Medical Science, Yazd, Iran.
- Medical Informatics Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
- Student Research Committee, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Zhila Taherzadeh
Zitieren
APA
Izadpanah, M., Pourahmadi, E., Bana, H. S., Dehghani, E., Akbari, M., Rezae, F. A., Yarmohammadi, F., Alnattah, A., Eslami, S., & Taherzadeh, Z. (2025). Creatine kinase and its muscle/brain isoenzyme as potential biomarkers for cardiovascular disease risk: A cross-sectional analysis of a population-based cohort. PLOS One. https://doi.org/10.1371/journal.pone.0338025
Vancouver
Izadpanah M, Pourahmadi E, Bana HS, Dehghani E, Akbari M, Rezae FA, et al. Creatine kinase and its muscle/brain isoenzyme as potential biomarkers for cardiovascular disease risk: A cross-sectional analysis of a population-based cohort. PLOS One. 2025. doi:10.1371/journal.pone.0338025
BibTeX
@article{Izadpanah2025,
author = {Izadpanah, Mahla and Pourahmadi, Elahe and Bana, Hamideh Safarian and Dehghani, Elham and Akbari, Masoumeh and Rezae, Fatemeh Asgharian and Yarmohammadi, Fatemeh and Alnattah, Ashraf and Eslami, Saeid and Taherzadeh, Zhila},
title = {Creatine kinase and its muscle/brain isoenzyme as potential biomarkers for cardiovascular disease risk: A cross-sectional analysis of a population-based cohort},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0338025}
}
EUVIMED